Molnupiravir is the first oral antiviral treatment for Covid to report clinical trial results.The tablet - molnupiravir - will be given twice a day to vulnerable patients recently diagnosed with the disease.
In a statement he said: "Today is a historic day for our country, as the UK is now the first country in the world to approve an antiviral that can be taken at home for Covid."Molnupiravir, developed by the US drug company Merck , is the first dedicated oral antiviral medication for Covid. The UK regulator, the MHRA, said the drug had been authorised for use in people who have mild to moderate Covid and at least one risk factor for developing severe illness such as obesity, old age, diabetes or heart disease.
Big Pharma's doing splendidly from this chimera virus: 'ca-ching'! 🤑
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: bbchealth - 🏆 143. / 63 Read more »
Source: Reuters - 🏆 2. / 97 Read more »